Immunoquantification of type I, III, IV, and V collagen in small samples of human lung parenchyma by Kuppevelt, T.H.M.S.M. van et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/22268
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
Pergamon
1357-2725(95)00047-X
Copyright ©  1995 Elsevier Science Ltd 
Printed in Great Britain. All rights reserved
1357-2725/95 $9.50 +  0.00
Int. J . Blochem. Ceil Biol. Vol. 27, No. 8, pp. 775-782, 1995
Inimunoquantification of Type I, III, IV and V 
Collagen in Small Samples of Human Lung 
Parenchyma
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f Department oj Biochemistry, University o f  Nijmegen, and 2 Vitro Chemie hv, Toernooiveld, 
Nijmegen* The Netherlands
The involvement of collagcn in pathological conditions underscores the need for sensitive, collagen 
type-specific assays, A method for the quantification of different types of collagen in lung has 
been developed. Human lung parenchyma is digested with cyanogen bromide which results in 
almost complete solubilization of collagcn to type-specific collagen peptides. The peptides arc 
quantified using inhibition enzyme immunoassays with type-specific antibodies. The 50%  
inhibition value for the type I collagen assay is 1 g type I collagen peptides, for the type III 
collagen assay 350 ng type III collagen peptides, for the type IV collagcn 200 ng type IV collagcn 
peptides, and for the type V collagen assay 50 ng type V collagen peptides. Using less than 1 mg 
lyophili/cd human parenchymal lung tissue it was established that the amount of collagen/mg dry 
tissue ( ± 8 0 ,  n =  10) is 84.6 ±  16.1 /ig for type I collagen, 26.6 ±  10.3 /ig for type III collagen,
9.6 ±  2.0 /ig for type IV collagen and 1.8 ± 0 ,3  fig for type V collagcn. The procedure is useful 
for the quantification of different types of collagen, including minor collagens, and requires only 
minimal sample preparation.
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IN TRO DU CTIO N
The lung is a highly dynamic and delicate organ, 
which depends to a great extent on the extra­
cellular matrix for the maintenance of its struc-
major air vessels. Type IV collagen is present in 
basement membranes and determines to a large 
extent the tensile strength of the b lood-air 
barrier (Konomi et a l 1981; West and 
Mathieucostello, 1992). Other types o f  collagen
lure. A continuous network of connective tissue (e g type v> yI> X) are present as well, each with
their own distribution, their function being un­
clear (Sano et a l 1981; Am enta et a l ,, 1988; 
Bearman and Flint, 1986). Collagens have been 
related to a number of pulmonary diseases like 
fibrosis, G oodpasture’s syndrome, and emphy-
clements extends all the way from the airways to 
the alveoli and from the visceral pleura into the 
lung. Collagen and elastin are the two main 
components of the extracellular matrix. While 
elastin appears to be the product of a single
gene, collagen is encoded for by more than 30 sema (Raghu et ^  i 985; Turner et a l. , 1992;
genes, giving rise to 19 types of collagen (Vuori Cordoso et al., 1993). The involvement of
and Crombrugghe, 1990; Van der Rest and collagen in pathological conditions underscores 
Garrone, 1991). Type I, II and III collagen neecj for sensitive, collagen type-specific
constitute the bulk of lung collagen, type II assays.
collagen being restricted to the cartilage of the most used assay to quantify collagen in
lung has been by measuring hydroxyproline 
(Pierce and Hocott, 1960; Laros et aL , 1972). 
This method is relatively inaccurate (some other
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4 5 ’C. The CNBr stock solution contained 
2 g/ml acetonitrile.
proteins like elastin also c o n ta in  h y d r o . ,y p n >  
line, Pierce and Hocott, I960: Chrzanowski 
et al., 1980), and cannot distinguish between
different types of collagen. In order to develop Immunization and antibodies
an accurate and precise method to quantify To obtain antibodies which react specificali)
different tvoes of collagen, two major demands , » . .1 ■ . . , l ì . , , ,
ameren y p _______ . t  ’ u.u:u„J;nn « r — with type-specific CNBr-denvcd collagen pep-have to be met: complete solubilization of colla- tides, Wistar rats (Ç, about ISOg) and New
gen, and type-specificity. With j^g^id toi the Zea|an(j wi1jte rabbits (05 or ‘(\  about 2 kg) were
first, lung collagen is notoriously difficult to 
solubilize (Clark et a l ,  1983). The most used 
technique to solubilize collagen has been limited 
pepsin digestion. In this way, however, only 
20-50% of the collagen is solubilized and the
s.c. injected at different spots with either 1 mg 
CNBr-derived collagen peptides in 1 ml 0.9% 
(w/v) NaCl or with 1 mg collagen in 1 ml 0,5 M 
HAc, and mixed with I ml complete Freunds'
resulting fraction is not representative for all adjuvant. After four weeks, animals were boost-
types of collagen (Last and Reiser, 1984), Fur­
thermore, subsequent isolation of different 
types of collagen is hampered by lengthy purifi­
cation procedures and concomitant losses, 
Digestion of whole tissue with cyanogen
ered with the same amount of antigen in incom­
plete Freunds" adjuvant. Animals were bled and 
the serum collected when the antibody titre did 
not further increase. Antibodies were screened 
for specificity by means of inhibition enzyme
bromide (CNBr) may overcome these problems immunoassays (see below), using ( NBr-derived
since it results in an almost complete solubil- c°Hagen peptides.
ization of collagen and requires minimal sample
treatment (Cheung et al> 1990; Light, 1982). Sample preparation
In addition, it results in collagen type-specific The procedure of sample preparation is out-
peptides (Bornstem, 1980). CNBr-derived colla- ,ined in Fig , Human ,ung parcnchymu was
gen peptides have been analysed in lung chro- powdered in a mortar prec0oled with liquid
matographically and/or electrophoretically nitrogen> and iyoph!Uzed. One millilitre 70%
(Kelley et a l ,  1989, Reiser and Last, 1980). form|c acjd was added to I mg material
However, these methods are cumbersome and 
of limited sensitivity (at best about 1 /¿g). Kiinor 
collagens can therefore not be analysed this 
way.
We here report a method to quantify different 
types of collagen in lung using immunoassays 
based on collagen type-specific antibodies reac­
tive with CNBr-derived peptides.
MATERIAL AND METHODS
Hum an lung specimens were obtained from
and the solution was bubbled with nitrogen 
for 10 min. CNBr (2 g/ml acetonitrile) was 
added to a final concentration of 8% (w/v) and 
incubation was for 2 hr at 45 ( \  After centrifu­
gation at 5000£ for lOmin, a similar amount 
of CNBr in 70% formic acid was added to 
the pellet and incubation was repeated, After 
centrifugation at 5000# for lOmin, the two 
supernatants were pooled and 10 Vol of deion­
ized water was added. The material
and * * if * % v in
lung lobes after lobectomy or pneumonectomy 1? mM ^ V V> N “C 1/0,05"'“
and immediately frozen in liquid nitrogen. The ween-*.0 (TBST) (pH 7.5) at a piotein concen-
samples were taken from peripheral lung tissue tratlon ot 2
that did not show any sign of the process for
which the patient (age range 55-71 years) was Analytical methods
operated.
Isolation o f  collagens
Type I, III, IV and V collagen were isolated 
from human placenta by limited pepsin diges­
tion and selective salt precipitation according to 
Miller and Rhodes (1982) and Abedin et al. 
(1981). CNBr-derived peptides were obtained by 
treatment of collagen (1 mg/ml 70% (v/v) 
formic acid) with 2% (w/v) CNBr for 4 hr at
Hydroxyproline content was measured ac­
cording to Huszar et al. (1980). Alkaline hy­
drolysis was for 2 hr at 120 C, The amount of 
collagen was estimated from the hydroxyproline 
content by multiplying this value with a factor
7, based on the observation that, on average, 
15% of the amino acids in collagen are hydroxy- 
prolines (Last and Reiser, 1984). Amino acid 
analysis was performed after hydrolysis under 
vacuum in 6 M HC1 at 100 C for 24 hr using a
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overnight at 4°C. One hundred microlitres of 
each well was transferred to a corresponding 
well of a polystyrene plate previously coated 
with CNBr-derived collagen peptides and incu­
bated for 30min at 22°C. Free antibodies, i.e. 
antibodies not bound by collagen in the sample, 
were allowed to complex with the coated CNBr- 
derived collagen peptides. After washing 3 times 
with TBST, bound antibodies were detected by 
incubation for 1 hr at 20°C with 100 ¡x\ rabbit 
anti-rat IgG (in case of rat sera) or goat an ti­
rabbit IgG (in case of rabbit sera) conjugated 
with peroxidase (1:1000 in TBST/BSA; Sigma, 
St Louis, Mo, U.S.A.). After washing, 100 ¿¿I of
substrate (0,04% (w/v) 0 -phenylenediamine and 
0.016% (w/v) H 20 2 in 24 mM citric acid/51 mM 
N a2H P 0 4 (pH 5.5)) was added. The reaction 
was allowed to proceed for 30 min at 22°C after 
which it was stopped by addition of 100 /¿I 4 M 
H2SG4. The colour developed was spectropho- 
tometrically measured at 492 nm. Each tissue 
digest was analysed at various dilutions in such 
a way that the data from at least two different 
dilutions were in the steep part o f  the standard 
curve.
Human lung parenchyma
'f
Powdering in liquid N 2 
lyophilization
i
Incubation for 2 h r  at 45°C 
in 70% formic acid/8% C N B r
i
Centrifugation 
(5000 g , 10 min)
Pellet
\
Incubation for 2 hr at 45°C 
in 70% formic neid/8fft CNBr
I
Centr ifugation  
(5000 £, 10 min)
T
Pellet  Supernatant
Lyophil ization and so lub i l iza t ion  in T B S T
Sample for immunoassays
Fig. L Preparation o f  human lung tissue for immunochemical analysis o f  collagen. TBST. 10 m M
Tris HCl/0.9% (w/v) NaCl/0.05% Tween-20.
}
S u p e r n a t a n t
Varian LC 5000 HPLC amino acid analyser. 
Protein was determined according to Lowry 
et aL (1951). Sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis was per­
formed according to Lacmmli (1970), using 
10% gels and reducing conditions (i.e. 5% 
2-mcrcaploethanol).
Non -equilibrium inhibition immunoassay
Non-equilibrium inhibition assays were car­
ried out according to Rennard et a l  (1980). 
Wells o f  polystyrene microtitre plates were 
coated by incubation overnight at 4°C with 
fi\ 20 mM carbonate buffer (pH 9,6) con­
taining 500 ng CNBr-derived peptides of the 
appropriate type of collagen isolated from pla­
centa. After incubation the wells were treated
with 200 //110 mM Tris HC1, 0.9% (w/v) NaCl 
(pH 7.5) containing 1% (w/v) bovine serum 
albumin for 1.5 hr at 20 C and washed 3 times 
with TBST. In the wells of round-bottom 
polyvinyl microtitre plates 5 0 /ri of the serum, 
diluted 1:2000 in TBST containing 1% (w/v) 
bovine serum albumin (TBST/BSA; pH 7.5) 
was mixed with 100 /ri sample and incubated
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Fig, 4 . Inhibition immunoassays for the quantification of type I.III, IV and V collagen. A volume o f 100 fd 
containing various amounts of CNBr peptides derived from different types of collagen were incubated 
overnight at 4 ( ’ wilh 5 0 /d of antibodies reactive with cyanogen bromide-derived peptides of type Ï (a), 
type III (h), type IV (e) and type V collagen (d). Next, 100/d of these mixtures were transferred to a 
corresponding well previously coated with 500 ng of CNBr-derived peptides or the appropriate type of 
collagen. After incubation for 30 min at 22 C, the antibodies bound to the well were detected by addition 
of peroxidase-conjugated secondary antibodies. After addition of substrate the colour developed was 
spectropholomelrieaily measured at 4()2 nm. The absorbance is expressed as a percentage of that without 
CNBr-derived peptides, which is taken as 100%. Type I, III, IV and V: CNBr-derived peptides from
placenta collagen type i, IH, IV and V, respectively.
one-third glycine and 10 13% proline) 
(Table 1). Flastin is not degraded by CNBr since 
it does not contain methionine residues. Hy- 
droxylysine, characteristic for collagen, is ab ­
sent from the pellet, as is methionine. 
Hydroxyproline residues constitute about 1.5% 
of the amino acid residues in the CNBr pellet;
Sepharose 4B to which CNBr-dcrived collagen 
peptides had been coupled did not alter specifi­
city in any way, For collagen type I and III, sera 
of rabbits immunized with collagen were used. 
These sera react with CNBr-derived collagen 
peptides (Fig. 4 ^ ) ,  like the anti-collagen anti­
bodies previously described (Bellon, 1985;
lung elastin contains about 1.4 1.7% hydroxy- Srinivas et at ., 1993). Antisera raised against 
proline (Pierce and HocotU I960; Chrzanowski CNBr-derived collagen fragments o f  type I and 
et «/., 1980).
Quantification o f  cottagens
The antisera used for the quantification of 
CNBr-derived collagen peptides (and hence 
for collagen itself) are type-specific (Fig. 4). 
Immunoadsorption using CNBr-activated
III collagen were not type-specific. For type IV 
and type V collagen, sera of rats immunized 
with CNBr-derived collagen peptides were used. 
These sera were type-specific (Fig. 4c,d). In the 
inhibition enzyme immunoassay for type I colla­
gen, 50% inhibition was achieved with about 
I /tg (Fig. 4a); for type III collagen this value
780 Toin H. van Kuppevelt et a l
was about 350 ng, for type IV collagen about while incomplete digestion and separation 
200 ng and for type V collagen about 50 ng would influence electrophoretical and ehro-
(Fig. 4b-d).
Using less than 1 mg of lyophilized parenchy-
matographical analysis.
The results described here are in line with
mal lung tissue all four collagens could be immunoassays reported for CNBr peptides 
quantified (Table 2). Type I collagen represents from collagens in kidney and placenta (Bellon, 
69% of the total collagen, type III 21 %, type IV 1985), chondrosarcoma cultures (Srtnivas et <//.,
1993) and skin and aorta (Schroter-Kermani
et aL, 1990). In comparison with the immuno-
equals the am ount of collagen calculated by assays for types IV and V collagen, those for the 
summing the am ount of type I, III, IV and V types I and III collagens are less sensitive. This,
however, is compensated by the relative abun­
dance of these interstitial collagens. The steep-
8% and type V 1.5%. The amount of collagen 
estimated by hydroxyproline measurement
collagen (Table 2). The ratio between the former 
and the latter is 1.02 ±  0.19 (mean ±  SD,
munoassays.
DISCUSSION
n =10). This shows that collagen is quantitat- ness of the inhibition curve for type 1 collagen 
ively assayed by a combination of the im- is relatively shallow and this will limit the
accuracy of the assay. Others have found similar 
results for type I collagen immunoassays (e.g. 
Schroter-Kermani et aL, 1990). In addition, the 
a3 and a4 chains of type IV collagen will not be 
analysed since type IV collagen from human 
placenta, which lacks these chains, was used as 
the antigen to prepare type IV specific anti- 
serum.
For human lung parenchyma, we found that 
type I collagen constitutes 69% of the total 
collagen, which is in agreement with data from
In this study we describe immunoassays to 
quantify different types of collagen, including 
minor collagens. There are three main 
advantages o f analysing CNBr-derived collagen 
peptides immunochemically instead of chro- 
matographically and/or electrophoretically, 
techniques that have been used for lung colla­
gens previously (Laurent et aL, 1981; Kirk et aL, the literature (66%, Seyer et aL, 1976). The 
1984), First, inhibition enzyme immunoassays value for collagen type III of 21% is somewhat 
are very sensitive: the detection limit o f type IV less than reported (33%, Seyer et aL, 1976). In
this study, however, other types than type I and 
III were not taken into consideration and whole
collagen is about 40 ng, of type V collagen about 
10 ng (Fig. 4). Second, various collagens (in this
study type I, III, IV and V) can be analysed lung instead of lung parenchyma was assayed, 
using the same sample. This is impossible using In parenchymal lung tissue from the rat, collu- 
electrophoretic techniques since many peptides gen type III represents 18% of the total collagen
(Kelley et at., 1989), while this is 33% in whole 
lung (Last and Reiser, 1980),
Type IV collagen (8% of the total collagen) 
has not been quantified before in lung. Lung 
parenchyma is rich in basement membranes 
(alveolar and endothelial basement membrane),
arise after CNBr digestion o f whole tissue and 
they overlap each other (Bornstein, 1980), In 
particular, m inor collagens give rise to many 
CNBr-derived peptides (e.g. each a-chain of 
type IV collagen contains 32 methionine 
residues, which form the site of cleavage). Third,
separation of the CNBr-derived peptides (often to which type IV collagen is restricted. In other 
two or more peptides are still linked) is not basement membrane-rich tissues type IV colla- 
necessary for immunochemical quantification, gen also constitutes a considerable proportion
Table 2, Content of type I, III, IV and V collagen and total collagen in human
lung parenchyma
Type I 
Type III 
Type IV 
Type V 
Total collagen 
(type I, III, IV, V added) 
Total collagen 
(assayed by hydroxyproline)
84.6 ¿16.1 69 + 4
26.6 ±  10.3 21 ± 5
9.6+ 2.0 8 ±  2
1.8 ±0.3 1.5 ±0.3
122.6 ±  23.2
124.0 +  36.0
Values are mean ±  SD (» = 10).
Quantification o f  collagens in human lung 781
of the collagen, e.g. placenta 3-21% (Bellon, 
1985; Garbisa et a i , 1980) and kidney 13% 
(Bellon and Borel, 1988), Type V collagen was 
estimated to constitute 1.5% of the collagen in 
human lung parenchyma. In total rat lung, type 
V collagen represents about 5% (Reiser and 
Last, 1983). In placental membranes a value of 
less than 3% was found (Miller et a i s 1991).
Since our method is very sensitive, collagens 
can be quantified in morphologically defined 
cryosections, as for instance in sections with 
only alveoli (where small vessels have been cut 
away) or in sections in which a pathological 
condition is prominent (e.g. fibrosis). A cryosec- 
tion o f 20 jim  x 1 cm x I cm contains about
15 jig  collagen (assuming 80% is air, 70% of the 
tissue is water, and 12% of the dry weight is 
collagen). This is sufficient collagen to quantify 
the different types using the immunoassays de­
scribed here.
In conclusion, we developed a technique for 
the quantification of different types of collagen 
in small tissue samples ( < 1 mg dry weight). The 
method is based on digestion of the tissue by 
CNBr and analysis of the resulting, type-specific 
peptides by inhibition enzyme immunoassays. 
The method combines simplicity (CNBr 
digestion is performed on whole tissue) with 
specificity and sensitivity (inhibition enzyme im­
munoassays). Minor collagens can be analysed 
in this wav.
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